Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review.

Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review.

BACKGROUND: To date, there has been no systematic examination of the relationship between international normalized ratio (INR) control measurements and the prediction of adverse events in patients with atrial fibrillation on oral anticoagulation. METHODS AND RESULTS: We searched MEDLINE, EMBASE, an...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Wan, Y, Heneghan, C, Perera, R, Roberts, N, Hollowell, J, Glasziou, P, Bankhead, C, Xu, Y
Format:	Journal article
Język:	English
Wydane:	2008

Podobne zapisy

Adverse events in clinically complex elderly patients with atrial fibrillation according to oral anticoagulation statusResearch in context
od: Tommaso Bucci, i wsp.
Wydane: (2024-12-01)

Rhythm control agents and adverse events in patients with atrial fibrillation.
od: Taylor, C, i wsp.
Wydane: (2010)

Individualised prediction of major bleeding in patients with atrial fibrillation treated with anticoagulation
od: Anne Pernille Toft-Petersen, i wsp.
Wydane: (2024-01-01)

Individualised prediction of major bleeding in patients with atrial fibrillation treated with anticoagulation.
od: Anne Pernille Toft-Petersen, i wsp.
Wydane: (2024-01-01)

Anticoagulant management in patients with atrial fibrillation.
od: Fitzmaurice, D, i wsp.
Wydane: (2009)

Machine Learning Approaches to Predict Major Adverse Cardiovascular Events in Atrial Fibrillation
od: Pedro Moltó-Balado, i wsp.
Wydane: (2024-01-01)

3021 Haemodialysis and atrial fibrillation anticoagulation decisions
od: Stephen Bacchi, i wsp.
Wydane: (2024-08-01)

Effects of Anticoagulant Therapy and Frailty in the Elderly Patients with Atrial Fibrillation
od: Ding J, i wsp.
Wydane: (2024-02-01)

Coffee consumption and adverse cardiovascular events in patients with atrial fibrillation
od: Vasco Iten, i wsp.
Wydane: (2024-12-01)

Time trends in atrial fibrillation-associated stroke and premorbid anticoagulation
od: Yiin, G, i wsp.
Wydane: (2018)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
od: I. Yu. Koroleva, i wsp.
Wydane: (2016-11-01)

Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
od: Yu. P. Skirdenko, i wsp.
Wydane: (2020-05-01)

Atrial Fibrillation Ablation without Interruption of Anticoagulation
od: Pasquale Santangeli, i wsp.
Wydane: (2011-01-01)

Challenging anticoagulation decisions in atrial fibrillation: a narrative review
od: Michael Griffin, i wsp.
Wydane: (2024-10-01)

Biomarkers for Predicting Left Atrial or Left Atrial Appendage Thrombus in Anticoagulated Patients with Nonvalvular Atrial Fibrillation
od: Xue Zhou, i wsp.
Wydane: (2020-01-01)

A systematic review of economic aspects of service interventions to increase anticoagulation use in atrial fibrillation
od: Jones, NR, i wsp.
Wydane: (2021)

Underuse of anticoagulation for atrial fibrillation - are we failing our patients?
od: Jones, N, i wsp.
Wydane: (2017)

Atrial fibrillation – NICE 2021 update and the focus on anticoagulation
od: Jones, N, i wsp.
Wydane: (2022)

CURRENT POSSIBILITIES OF ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION
od: M. Yu. Gilyarov, i wsp.
Wydane: (2015-10-01)

Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage
od: A. S. Gerasimenko, i wsp.
Wydane: (2021-05-01)

Challenges of anticoagulant treatment in atrial fibrillation with liver disease
od: Alina Doina Nicoara, i wsp.
Wydane: (2024-10-01)

Anticoagulant therapy in catheter ablation of atrial fibrillation and flutter
od: M. V. Serova, i wsp.
Wydane: (2021-09-01)

Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and Mortality
od: Łukasz Pyka MD, PhD, i wsp.
Wydane: (2023-12-01)

Self-monitoring of oral anticoagulation: a systematic review and meta-analysis.
od: Heneghan, C, i wsp.
Wydane: (2006)

Sex-specific comparative outcomes between oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis
od: Gregory Y H Lip, i wsp.
Wydane: (2024-08-01)

Left Atrial Appendage Closure in Atrial Fibrillation: A World without Anticoagulation?
od: Tahmeed Contractor, i wsp.
Wydane: (2011-01-01)

Moderate/severe biatrial dilation predicts adverse events after ablation in atrial fibrillation with heart failure
od: Yan Yao, i wsp.
Wydane: (2024-10-01)

Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)
od: Raffaele De Caterina, i wsp.
Wydane: (2019-03-01)

PREDICTORS OF THE RISK OF HEMORRHAGIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING LONGTERM THERAPY WITH DIRECT ORAL ANTICOAGULANTS
od: A. А. Sokolova, i wsp.
Wydane: (2017-12-01)

Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials
od: Jennifer R. Brown, i wsp.
Wydane: (2017-10-01)

Challenges of anticoagulant therapy in patients with atrial fibrillation in clinical practice.
od: Hobbs, R
Wydane: (2012)

ANTICOAGULATION IN PATIENTS WITH ATRIAL-FIBRILLATION - EXPERT SOFTWARE MAY BE THE ANSWER
od: Fitzmaurice, D, i wsp.
Wydane: (1994)

Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction
od: Z. D. Kobalava, i wsp.
Wydane: (2021-03-01)

THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY
od: M. Yu. Gilyarov
Wydane: (2015-12-01)

Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation
od: Dana Prídavková, i wsp.
Wydane: (2019-01-01)

Factors determining adherence to anticoagulant therapy in patients with atrial fibrillation
od: D. V. Pevzner, i wsp.
Wydane: (2023-06-01)

Specifics of anticoagulation in combination with atrial fibrillation and chronic kidney disease
od: N. Sh. Zagidullin, i wsp.
Wydane: (2021-10-01)

NOVEL ANTICOAGULANTS FOR THROMBOEMBOLIC COMPLICATIONS PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
od: D. A. Itkin, i wsp.
Wydane: (2015-02-01)

Contribution of anticoagulant therapy adherence to the risk of complications of atrial fibrillation
od: Yu. P. Skirdenko, i wsp.
Wydane: (2019-03-01)

New safety standards for anticoagulant therapy in the treatment of atrial fibrillation
od: E. I. Baranova
Wydane: (2018-11-01)